CD8A and neoplasm: Recent studies involving T cell and ILC interaction in immunodeficient mice also revealed that spleen resident ILC2s help antigen-presenting cells (APCs) cross prime CD8+ tumour infiltrating T cells and central memory B cells (Moral et al., 2020).